Annovis Bio Inc (ANVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,462 | -3,757 | -2,751 | -442 | -991 |
| Depreciation Amortization | 1 | 1 | 1 | 1 | 5 |
| Accounts receivable | 735 | 310 | 536 | 697 | -735 |
| Accounts payable and accrued liabilities | -696 | -898 | -913 | -983 | 969 |
| Other Working Capital | -401 | -1,215 | -669 | -556 | 416 |
| Other Operating Activity | 1,852 | 2,354 | 1,515 | 312 | -141 |
| Operating Cash Flow | $-3,971 | $-3,205 | $-2,282 | $-970 | $-477 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 530 |
| Common Stock Issued | 12,044 | 12,034 | 12,034 | 12,084 | N/A |
| Other Financing Activity | 0 | 9 | 9 | 5 | -87 |
| Financing Cash Flow | $12,044 | $12,044 | $12,044 | $12,089 | $443 |
| Beginning Cash Position | 2 | 2 | 2 | 2 | 35 |
| End Cash Position | 8,075 | 8,841 | 9,763 | 11,121 | 2 |
| Net Cash Flow | $8,073 | $8,839 | $9,761 | $11,119 | $-34 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,971 | -3,205 | -2,282 | -970 | -477 |
| Free Cash Flow | -3,971 | -3,205 | -2,282 | -970 | -477 |